Back to Companies who have applied for FDA Drug Approval

FDA Drug Approval Applications Sponsored by WYETH PHARMS INC

Application NumberDrugs/ProductsApplication TypeMost Recent Label Available FlagCurrent Patent FlagAction TypeChemical TypeTher PotentialOrphan Code
004782 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
005897 New Drug Application Approval
010402 New Drug Application Approval New formulation (S) Standard review drug
011963 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
012796 New Drug Application Approval New formulation (P) Priority review drug
013026 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
016418 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
018031 New Drug Application Approval New combination (S) Standard review drug
018922 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
018972 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
019190 New Drug Application Approval New formulation (S) Standard review drug
019816 New Drug Application Approval New formulation (S) Standard review drug
020088 New Drug Application Approval New formulation (P) Priority review drug
020151 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
020216 New Drug Application Approval
020303 New Drug Application Approval New combination (S) Standard review drug
020377 New Drug Application Approval New formulation (S) Standard review drug (V) Orphan drug
020527 New Drug Application Approval New formulation (S) Standard review drug
020584 New Drug Application Approval New formulation (S) Standard review drug
020627 New Drug Application Approval New formulation (S) Standard review drug
020699 New Drug Application Approval New formulation (S) Standard review drug
020987 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
020988 New Drug Application Approval New formulation (S) Standard review drug
021174 New Drug Application Approval New molecular entity (NME) (P) Priority review drug (V) Orphan drug
021417 New Drug Application Approval New indication (S) Standard review drug
021864 New Drug Application Approval New manufacturer (S) Standard review drug
021992 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
022020 New Drug Application Approval New formulation (S) Standard review drug
050545 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
050684 New Drug Application Approval New molecular entity (NME); New combination (S) Standard review drug
050750 New Drug Application Approval New formulation (S) Standard review drug
062750 Abbreviated New Drug Application Approval
103694 Biologic License Application Approval
203341 New Drug Application Approval New molecular entity (NME) (S) Standard review drug (V) Orphan drug

Back to Companies who have applied for FDA Drug Approval